Anzeige
Mehr »
Login
Sonntag, 23.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EDH3 | ISIN: US04537Y2081 | Ticker-Symbol: CUL
Stuttgart
21.02.25
21:32 Uhr
0,204 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ASPIRA WOMENS HEALTH INC Chart 1 Jahr
5-Tage-Chart
ASPIRA WOMENS HEALTH INC 5-Tage-Chart

Aktuelle News zur ASPIRA WOMENS HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ASPIRA WOMENS HEALTH Aktie jetzt für 0€ handeln
13.02.Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement168AUSTIN, TX / ACCESS Newswire / February 13, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic...
► Artikel lesen
11.02.Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors382AUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic...
► Artikel lesen
11.02.Aspira Women's Health Inc. - S-1/A, General form for registration of securities2
10.02.Aspira Women's Health Inc. - 8-K, Current Report-
31.01.Aspira Women's Health Inc. - S-1/A, General form for registration of securities-
31.01.Aspira Women's Health Inc. - 8-K, Current Report-
13.01.Aspira Women's Health Inc. - 8-K, Current Report2
10.01.Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations305Interim CFO John Kallassy to Depart January 10 AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq:AWH), a bio-analytical based women's health...
► Artikel lesen
08.01.Aspira Women's Health Inc. - S-1, General form for registration of securities-
31.12.24Aspira Women's Health Inc. - 8-K, Current Report-
16.12.24Aspira Women's Health Inc. - 8-K, Current Report-
16.12.24Aspira Women's Health CEO steps down, interim appointed5
16.12.24CEO von Aspira Women's Health tritt zurück, Interimsnachfolger ernannt1
16.12.24Aspira Women's Health appoints Sandra Milligan as interim CEO as Sandford departs2
16.12.24Aspira Women's Health Inc.: Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO135AUSTIN, Texas, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ: AWH), a bio-analytical based women's health company focused on the development of gynecologic...
► Artikel lesen
03.12.24Aspira Women's Health Inc.: Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award106AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease...
► Artikel lesen
19.11.24Aspira Women's Health Inc. - 10-Q, Quarterly Report-
14.11.24Aspira Women's Health reports Q3 results1
14.11.24Aspira Women's Health Inc. - 8-K, Current Report-
07.11.24Aspira Women's Health Inc.: Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch1
Seite:  Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1